| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |